As the Senior Program Research Nurse Practitioner for the Leukemia Program at Dana Farber Cancer Institute, Ilene Galinsky practices autonomously and in collaboration with physicians and other members of the multidisciplinary team in the diagnosis, treatment, and management of patients with acute and chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS), myelofibrosis, and other bone marrow failure bone marrow failure: A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be… diseases. Ms. Galinsky serves as a resource, educator, mentor, administrator, and researcher to physicians, nurses, physician assistants, and nurse practitioners as well as clinical coordinators. In addition, she assists in protocol protocol: An action plan that describes what will be done in a clinical trial and how it will be carried out. This plan is reviewed and approved by a committee at each place doing the clinical trial. This committee is known as the Institutional Review Board. development and execution. She has experience as a lecturer for MDS, CMS, and acute leukemia and has contributed to more than 40 abstracts and publications in the medical literature. Ms. Galinsky earned her MSN and BSN from Northeastern University in Boston, MA.